These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

352 related articles for article (PubMed ID: 19566488)

  • 1. Role of MCP-1 in cardiovascular disease: molecular mechanisms and clinical implications.
    Niu J; Kolattukudy PE
    Clin Sci (Lond); 2009 Jul; 117(3):95-109. PubMed ID: 19566488
    [TBL] [Abstract][Full Text] [Related]  

  • 2. MCP-1 causes cardiomyoblast death via autophagy resulting from ER stress caused by oxidative stress generated by inducing a novel zinc-finger protein, MCPIP.
    Younce CW; Kolattukudy PE
    Biochem J; 2010 Jan; 426(1):43-53. PubMed ID: 19925454
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nonendothelial mesenchymal cell-derived MCP-1 is required for FGF-2-mediated therapeutic neovascularization: critical role of the inflammatory/arteriogenic pathway.
    Fujii T; Yonemitsu Y; Onimaru M; Tanii M; Nakano T; Egashira K; Takehara T; Inoue M; Hasegawa M; Kuwano H; Sueishi K
    Arterioscler Thromb Vasc Biol; 2006 Nov; 26(11):2483-9. PubMed ID: 16960104
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Blocking mast cell-mediated type I hypersensitivity in experimental allergic conjunctivitis by monocyte chemoattractant protein-1/CCR2.
    Tominaga T; Miyazaki D; Sasaki S; Mihara S; Komatsu N; Yakura K; Inoue Y
    Invest Ophthalmol Vis Sci; 2009 Nov; 50(11):5181-8. PubMed ID: 19553621
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibition of the angiogenesis by the MCP-1 (monocyte chemoattractant protein-1) binding peptide.
    Kim MY; Byeon CW; Hong KH; Han KH; Jeong S
    FEBS Lett; 2005 Mar; 579(7):1597-601. PubMed ID: 15757647
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Recent developments in CCR2 antagonists.
    Xia M; Sui Z
    Expert Opin Ther Pat; 2009 Mar; 19(3):295-303. PubMed ID: 19441905
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Chemokines in the pathogenesis of vascular disease.
    Charo IF; Taubman MB
    Circ Res; 2004 Oct; 95(9):858-66. PubMed ID: 15514167
    [TBL] [Abstract][Full Text] [Related]  

  • 8. MCP-1: chemoattractant with a role beyond immunity: a review.
    Yadav A; Saini V; Arora S
    Clin Chim Acta; 2010 Nov; 411(21-22):1570-9. PubMed ID: 20633546
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Monocyte chemoattractant protein-1 (CCL2) in inflammatory disease and adaptive immunity: therapeutic opportunities and controversies.
    Daly C; Rollins BJ
    Microcirculation; 2003 Jun; 10(3-4):247-57. PubMed ID: 12851642
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibition of MCP-1/CCR2 signaling does not inhibit intimal proliferation in a mouse aortic transplant model.
    Alexis JD; Pyo RT; Chereshnev I; Katz J; Rollins BJ; Charo IF; Taubman MB
    J Vasc Res; 2008; 45(6):538-46. PubMed ID: 18463419
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inflammation, endoplasmic reticulum stress, autophagy, and the monocyte chemoattractant protein-1/CCR2 pathway.
    Kolattukudy PE; Niu J
    Circ Res; 2012 Jan; 110(1):174-89. PubMed ID: 22223213
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Monocyte chemotactic protein-induced protein (MCPIP) promotes inflammatory angiogenesis via sequential induction of oxidative stress, endoplasmic reticulum stress and autophagy.
    Roy A; Kolattukudy PE
    Cell Signal; 2012 Nov; 24(11):2123-31. PubMed ID: 22820500
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Anti-monocyte chemoattractant protein-1 gene therapy for cardiovascular diseases.
    Kitamoto S; Egashira K
    Expert Rev Cardiovasc Ther; 2003 Sep; 1(3):393-400. PubMed ID: 15030267
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Macrophages, inflammation, adipose tissue, obesity and insulin resistance].
    Bastarrachea RA; López-Alvarenga JC; Bolado-García VE; Téllez-Mendoza J; Laviada-Molina H; Comuzzie AG
    Gac Med Mex; 2007; 143(6):505-12. PubMed ID: 18269082
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hyperglycaemia-induced cardiomyocyte death is mediated via MCP-1 production and induction of a novel zinc-finger protein MCPIP.
    Younce CW; Wang K; Kolattukudy PE
    Cardiovasc Res; 2010 Sep; 87(4):665-74. PubMed ID: 20356868
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Isolation and structures of novel fungal metabolites as chemokine receptor (CCR2) antagonists.
    Herath KB; Jayasuriya H; Ondeyka JG; Polishook JD; Bills GF; Dombrowski AW; Cabello A; Vicario PP; Zweerink H; Guan Z; Singh SB
    J Antibiot (Tokyo); 2005 Nov; 58(11):686-94. PubMed ID: 16466022
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Physiological and pathophysiological roles of adiponectin and adiponectin receptors in the integrated regulation of metabolic and cardiovascular diseases.
    Yamauchi T; Kadowaki T
    Int J Obes (Lond); 2008 Dec; 32 Suppl 7():S13-8. PubMed ID: 19136982
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CCR3, CCR2A and macrophage inflammatory protein (MIP)-1a, monocyte chemotactic protein-1 (MCP-1) in the mouse hippocampus during and after pilocarpine-induced status epilepticus (PISE) .
    Xu JH; Long L; Tang YC; Zhang JT; Hut HT; Tang FR
    Neuropathol Appl Neurobiol; 2009 Oct; 35(5):496-514. PubMed ID: 19490431
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Stretch-induced activation of the transcription factor activator protein-1 controls monocyte chemoattractant protein-1 expression during arteriogenesis.
    Demicheva E; Hecker M; Korff T
    Circ Res; 2008 Aug; 103(5):477-84. PubMed ID: 18669921
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Significant involvement of CCL2 (MCP-1) in inflammatory disorders of the lung.
    Rose CE; Sung SS; Fu SM
    Microcirculation; 2003 Jun; 10(3-4):273-88. PubMed ID: 12851645
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.